Company Filing History:
Years Active: 2021
Title: Bodhan Waszkowycz: Innovator in Cancer Research
Introduction
Bodhan Waszkowycz is a notable inventor based in Manchester, GB. He has made significant contributions to the field of cancer research through his innovative work on PARG inhibitory compounds. His research focuses on developing compounds that can inhibit the activity of the PARG enzyme, which is implicated in various proliferative disorders, including cancer.
Latest Patents
Bodhan Waszkowycz holds a patent for PARG inhibitory compounds. The present invention relates to compounds of formula I that function as inhibitors of PARG (Poly ADP-ribose glycohydrolase) enzyme activity. The compounds are designed to be used in pharmaceutical compositions for the treatment of proliferative disorders, such as cancer, as well as other diseases where PARG activity is a factor. He has 1 patent to his name.
Career Highlights
Bodhan is currently associated with Cancer Research Technology Limited, where he continues to advance his research in the field of cancer treatment. His work is crucial in developing new therapeutic strategies that target specific enzyme activities related to cancer progression.
Collaborations
Bodhan has collaborated with notable colleagues, including Alison E McGonagle and Allan Michael Jordan. These collaborations enhance the research efforts aimed at finding effective treatments for cancer and other related diseases.
Conclusion
Bodhan Waszkowycz is a dedicated inventor whose work on PARG inhibitory compounds represents a significant advancement in cancer research. His contributions are vital for the development of new therapeutic options for patients suffering from proliferative disorders.